Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT
Abstract
Background In a previous trial we reported that the neuroprotective, anti-inflammatory antibiotic minocycline lessened the negative symptoms of schizophrenia compared with placebo over 1 year. The BeneMin study aimed to replicate this benefit and to determine whether or not there was associated preservation of grey matter, reduction in circulating inflammatory cytokines and enhancement of cognition. Objectives To determine the efficacy of...
Paper Details
Title
Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT
Published Date
Aug 1, 2019
Volume
6
Issue
7
Pages
1 - 66
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History